Waters Co. (NYSE:WAT) Position Lifted by TD Asset Management Inc

TD Asset Management Inc lifted its holdings in Waters Co. (NYSE:WATFree Report) by 215.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 425,219 shares of the medical instruments supplier’s stock after buying an additional 290,511 shares during the quarter. TD Asset Management Inc owned approximately 0.72% of Waters worth $139,995,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of WAT. Ieq Capital LLC lifted its position in shares of Waters by 66.8% in the 3rd quarter. Ieq Capital LLC now owns 1,511 shares of the medical instruments supplier’s stock worth $414,000 after buying an additional 605 shares during the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its position in shares of Waters by 9.7% in the 3rd quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 55,889 shares of the medical instruments supplier’s stock worth $15,325,000 after buying an additional 4,936 shares during the last quarter. Barclays PLC lifted its position in shares of Waters by 8.1% in the 3rd quarter. Barclays PLC now owns 133,069 shares of the medical instruments supplier’s stock worth $36,488,000 after buying an additional 9,922 shares during the last quarter. Metis Global Partners LLC lifted its position in Waters by 10.0% in the 3rd quarter. Metis Global Partners LLC now owns 4,470 shares of the medical instruments supplier’s stock valued at $1,226,000 after purchasing an additional 406 shares during the last quarter. Finally, New York State Common Retirement Fund lifted its position in Waters by 0.9% in the 3rd quarter. New York State Common Retirement Fund now owns 214,252 shares of the medical instruments supplier’s stock valued at $58,750,000 after purchasing an additional 1,991 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. Robert W. Baird cut their price objective on shares of Waters from $319.00 to $312.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 8th. TD Cowen lifted their price objective on shares of Waters from $350.00 to $358.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th. Barclays cut their price objective on shares of Waters from $300.00 to $295.00 and set an “underweight” rating on the stock in a research report on Wednesday, May 8th. Stifel Nicolaus lifted their price objective on shares of Waters from $330.00 to $332.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th. Finally, Evercore ISI lifted their price objective on shares of Waters from $320.00 to $340.00 and gave the company an “in-line” rating in a research report on Thursday, April 4th. One investment analyst has rated the stock with a sell rating and ten have issued a hold rating to the company. According to data from MarketBeat.com, Waters has a consensus rating of “Hold” and a consensus price target of $305.78.

Check Out Our Latest Analysis on Waters

Waters Price Performance

Waters stock traded down $3.94 during trading hours on Wednesday, hitting $327.90. 88,875 shares of the company traded hands, compared to its average volume of 422,585. The firm’s 50-day simple moving average is $332.53 and its two-hundred day simple moving average is $321.02. The firm has a market cap of $19.45 billion, a P/E ratio of 32.57, a P/E/G ratio of 5.35 and a beta of 0.98. The company has a quick ratio of 1.30, a current ratio of 1.94 and a debt-to-equity ratio of 1.60. Waters Co. has a 1-year low of $231.90 and a 1-year high of $367.21.

Waters (NYSE:WATGet Free Report) last announced its quarterly earnings data on Tuesday, May 7th. The medical instruments supplier reported $2.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.10 by $0.11. The company had revenue of $636.80 million for the quarter, compared to analysts’ expectations of $635.57 million. Waters had a net margin of 20.75% and a return on equity of 66.59%. The business’s revenue was down 7.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.49 EPS. As a group, analysts forecast that Waters Co. will post 11.86 earnings per share for the current fiscal year.

Insider Transactions at Waters

In other news, Director Christopher A. Kuebler sold 4,000 shares of Waters stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $361.64, for a total value of $1,446,560.00. Following the transaction, the director now owns 14,716 shares of the company’s stock, valued at approximately $5,321,894.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Linda Baddour sold 500 shares of Waters stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $355.54, for a total value of $177,770.00. Following the transaction, the director now directly owns 2,250 shares of the company’s stock, valued at $799,965. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Christopher A. Kuebler sold 4,000 shares of Waters stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $361.64, for a total transaction of $1,446,560.00. Following the completion of the transaction, the director now directly owns 14,716 shares in the company, valued at $5,321,894.24. The disclosure for this sale can be found here. Corporate insiders own 0.82% of the company’s stock.

About Waters

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Articles

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.